Waystar Is Organizing for the Autonomous Revenue Cycle

Waystar's newest executive appointments look like a leadership story. The more important signal is the operating model behind them: product, technology and commercialization are being aligned around a revenue cycle that increasingly orchestrates work and takes action.

Waystar named Amit Khanna Chief Product and Technology Officer and promoted longtime executive Todd Woods to Chief Commercial Officer on August 25. Khanna most recently led Salesforce's global healthcare business. Woods has spent 24 years at Waystar and now takes responsibility for commercial strategy and client relationships.

Those are notable appointments on their own. But Waystar's language around the move is more important than the titles.

The company said the appointments are intended to advance its vision for an autonomous revenue cycle. CEO Matt Hawkins described a market in which intelligent technology increasingly orchestrates complex workflows and takes action toward resolution.

That is a meaningful change in how one of healthcare payments' largest infrastructure companies is describing the future.

Autonomous RCM is moving from vendor category to operating thesis

For the last several years, "AI in RCM" has often meant a collection of narrow applications: coding assistance, denial prioritization, payment prediction, call automation, claim-status work or appeal generation.

The newer thesis is broader. Instead of improving one task, the system coordinates many tasks and moves work forward with less human intervention.

That distinction matters. A denial model that predicts which accounts deserve attention is still a tool. A system that detects the denial, gathers clinical and payer context, determines the next action, executes or drafts it, monitors the result and escalates only when needed is closer to an operating layer.

The leadership structure tells us what comes next

Khanna's background is useful context. Salesforce is not primarily a healthcare RCM company; it is an enterprise platform company built around data, workflow, applications and large-scale commercialization. Bringing that experience into the product and technology seat suggests the next RCM competition may be less about isolated features and more about platform architecture.

At the same time, promoting Woods into the top commercial role matters because autonomous workflows only become meaningful if health systems actually adopt them. RCM has no shortage of promising technology that stalls in pilots because implementation, trust, workflow redesign or measurable ROI never reaches production scale.

Putting product and technology transformation alongside commercial execution is therefore logical. The next phase of RCM AI is not only a technical race. It is an adoption race.

Waystar has a distribution advantage

Waystar says its platform serves more than 30,000 clients representing more than one million providers and processes billions of healthcare payment transactions annually. That footprint creates an obvious strategic advantage.

An AI startup can build a strong denial agent. A scaled infrastructure company can potentially place automation inside workflows where claims, remittances, eligibility, prior authorization, payment and patient-financial data already move.

That does not guarantee better AI. But it can dramatically lower the distance between an AI capability and an executable revenue-cycle action.

And as RCM becomes more agentic, that distance matters.

The competitive moat may shift toward workflow access

The first generation of healthcare AI competition focused heavily on model performance. That shift is also visible in our analysis of Waystar's KLAS RCM performance and the Iodine + Waystar CDI deep dive. That advantage is becoming harder to sustain as frontier models improve and vendors gain access to similar underlying intelligence.

The more durable moats may be elsewhere:

• access to transaction and workflow data;
• integration into systems where actions can actually be executed;
• historical outcome data that improves routing and decision logic;
• governance and controls required by enterprise buyers;
• distribution into thousands of provider organizations; and
• proof that automation produces measurable financial outcomes.

Waystar already owns meaningful pieces of that stack. RevCycleAI has tracked that position in our Waystar Vendor Deep Dive, including the company's workflow footprint, product breadth and strategic position.

What this means for RCM AI startups

The announcement should not be interpreted as "incumbents win." Startups continue to move faster in many areas and can attack workflows that larger platforms underserve.

But the burden of differentiation is rising.

A point solution that simply applies a general-purpose model to an RCM task becomes easier to replicate. A company with proprietary workflow data, a deep integration, a unique operating process, unusually strong decision quality or a defensible distribution channel has a more durable position.

The more Waystar, Epic, Oracle, clearinghouses and other infrastructure companies turn AI into a native platform capability, the less compelling "we added AI to this workflow" becomes as a standalone value proposition.

The buyer question is changing too

Health systems should expect vendor evaluation to change with the architecture.

The relevant question is no longer only, "How accurate is the model?" It becomes:

• What data can the system see?
• What decisions can it make?
• What actions can it take?
• How does it know when not to act?
• What requires human escalation?
• How are actions audited?
• How is financial impact measured?

Those are much closer to operating-model questions than software-feature questions.

RCAI View

Waystar's executive appointments are worth tracking because they reinforce a market signal that is becoming difficult to ignore.

Autonomous RCM is becoming the strategic end state, not merely a product label.

The winners will likely combine model intelligence with context, workflow access, orchestration, execution, controls and enterprise distribution. That favors companies that already sit close to transaction flow—but it also creates openings for focused AI companies that can prove materially better outcomes in workflows incumbents cannot solve well.

What matters now is not which company uses the word "agent" most aggressively.

It is which companies can reliably move revenue-cycle work from signal → decision → action → measurable resolution with less human intervention.

Waystar is now organizing its leadership around that future.